TrialDiabetes, obesity & metabolism2019

IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy.

Eden Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.